CoChat

Expansion and preferential activation of the CD14+CD16+ monocyte subset during multiple sclerosis

Chuluundorj, Delgertsetseg, Harding, Scott A, Abernethy, David, La Flamme, Anne Camille · 2014 · Immunology & Cell Biology
Cited by 116

The DOI matches its Crossref record; 6 of the 6 references it cites were found in a registry or an index.

Abstract

Multiple sclerosis (MS) is an immune‐driven, demyelinating disease of the central nervous system (CNS). Although many types of immune cells are involved in disease progression, activated monocytes are believed to be one of the first to arrive to the brain and initiate inflammation. However, little is known about how the two main monocyte subsets, CD14++CD16− and CD14+CD16+, are involved in MS. To understand how the phenotype and responses of these monocyte subsets are altered during MS, total monocytes and the purified monocyte subsets from healthy subjects (n=29) and MS patients (n=20) were characterized ex vivo and stimulated in vitro with lipopolysaccharide (LPS). The ex vivo analyses showed that total monocytes from MS patients had significantly elevated levels of CD40, CD86, HLA‐DR, CD64 and C‐C motif chemokine receptor 2 (CCR2), and this elevation was most marked on CD16+ monocytes. In vitro stimulation with LPS led to an increase in CD86, HLA‐DR, CD64 and IL‐6 production by monocytes from MS patients. Furthermore, in purified cultures, CD14+ monocytes were found to be the main producers of IL‐10 while CD16+ monocytes produced more IL‐12. In monocytes from MS patients, both subsets produced substantially more IL‐6, and the production of IL‐10 by the CD16+ subset was also significantly elevated compared with healthy monocytes. Together these findings highlight the important contribution of the CD16+ monocyte subset in driving inflammatory responses during MS.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1038/icb.2014.15

Cites

6 of 6 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 6 references

Cited by

See all 116

Metadata

Authors
Chuluundorj, D., Harding, S. A., Abernethy, D., & La Flamme, A. C.
Venue
Immunology & Cell Biology
Publisher
Wiley
Published
2014-03-18
Volume
92
Issue
6
Pages
509-517
ISSN
  • 0004-945X (ISSN-L)
  • 0818-9641
  • 1440-1711
OpenAlex
W2008010286
Cited by
116
References
6
FWCI
5.89
Type
journal article
Language
en
Open access
closed

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Expansion and preferential activation of the CD14+CD16+ monocyte subset during multiple sclerosis. https://app.cochat.ai/papers/10.1038/icb.2014.15
The paper
Chuluundorj, D., Harding, S. A., Abernethy, D., & La Flamme, A. C. (2014). Expansion and preferential activation of the CD14+CD16+ monocyte subset during multiple sclerosis. Immunology & Cell Biology. https://doi.org/10.1038/icb.2014.15

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.